Form 4: Guardant Health Director Roberto Mignone Acquires Stock Options and Restricted Stock Units

Director Roberto Mignone of Guardant Health, Inc. acquired stock options and restricted stock units on November 8, 2024, as part of a compensation package.

Summary

• Roberto Mignone, a director at Guardant Health, Inc., was granted stock options and restricted stock units on November 8, 2024.
• The stock options allow Mignone to purchase 19,535 shares of common stock at an exercise price of $28.61.
• The restricted stock units represent 12,671 shares of common stock.
• Both the stock options and restricted stock units vest over a four-year period, with 25% vesting after one year and the remaining 75% vesting monthly over the following three years.
• The vesting start date for both awards is October 21, 2024.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, which is generally positive for aligning interests, but not a major event.

Positives

• The grant of stock options and restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Industry Context

This is a standard practice for compensating directors and aligning their interests with the company's performance in the biotechnology industry.

Comparison to Industry Standards

• Stock options and restricted stock units are common forms of equity compensation for directors in publicly traded companies, particularly in the biotech sector.
• The four-year vesting schedule with a one-year cliff is a typical structure for these types of awards.
• Companies like Illumina, Exact Sciences, and Myriad Genetics also use similar equity compensation packages for their directors.

Stakeholder Impact

• The grant of equity to a director can be seen positively by shareholders as it aligns interests.
• The vesting schedule encourages long-term commitment from the director.

Key Dates

Keywords

stock options, restricted stock units, insider trading, Guardant Health, equity compensation, director, vesting